752 related articles for article (PubMed ID: 16872305)
1. Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.
Xu W; Song S; Huang Y; Gong Z
J Gastroenterol Hepatol; 2006 Aug; 21(8):1250-6. PubMed ID: 16872305
[TBL] [Abstract][Full Text] [Related]
2. [Effects of perindopril and valsartan on the expression of TGF beta 1 and TGF beta receptor II mRNA, Smad3 and Smad7 in experimental hepatic fibrotic rats].
Gong ZJ; Song SL; Huang YQ; Ruan P
Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):737-40. PubMed ID: 15619341
[TBL] [Abstract][Full Text] [Related]
3. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
[TBL] [Abstract][Full Text] [Related]
4. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
5. JinSanE decoction, a chinese herbal medicine, inhibits expression of TGF-beta1/Smads in experimental hepatic fibrosis in rats.
Song SL; Gong ZJ; Huang YQ; Zhang QR; Huang TX
Am J Chin Med; 2006; 34(6):1047-61. PubMed ID: 17163593
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
Zhong M; Zhang Y; Miao Y; Li L; Gong HP; Ma X; Sun H; Zhang W
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):232-6. PubMed ID: 16677501
[TBL] [Abstract][Full Text] [Related]
7. [Effect of ACE-I and AT-1 receptor blocker on the progression of CCl(4)-inducing rat hepatic fibrogenesis].
Li X; Meng Y; Zhang ZS; Yang XS; Wu PS
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1241-5. PubMed ID: 12930639
[TBL] [Abstract][Full Text] [Related]
8. Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.
Song SL; Gong ZJ; Zhang QR; Huang TX
World J Gastroenterol; 2005 Apr; 11(15):2269-76. PubMed ID: 15818738
[TBL] [Abstract][Full Text] [Related]
9. Effects of angiotensin II receptor antagonist on expression of collagen III, collagen V, and transforming growth factor beta1 in the airway walls of sensitized rats.
Du YC; Xu JY; Zhang SJ
Chin Med J (Engl); 2004 Jun; 117(6):908-12. PubMed ID: 15198897
[TBL] [Abstract][Full Text] [Related]
10. Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats.
Wang T; Yin KS; Liu KY; Lu GJ; Li YH; Chen JD
Chin Med J (Engl); 2008 Nov; 121(22):2312-9. PubMed ID: 19080339
[TBL] [Abstract][Full Text] [Related]
11. [The effect of angiotensin II type 1 receptor blocker valsartan in preventing hepatic fibrosis induced by dimethylnitrosamine in rats].
Shen FJ; Zhu YK; Jia JD; Ma H; Wang BE
Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):605-8. PubMed ID: 15504291
[TBL] [Abstract][Full Text] [Related]
12. [The effects of renin-angiotensin system blockade on the liver steatosis in rats on long-term high-fat diet].
Chen YH; Yuan L; Chen YY; Qi CJ
Zhonghua Nei Ke Za Zhi; 2008 Mar; 47(3):197-201. PubMed ID: 18785501
[TBL] [Abstract][Full Text] [Related]
13. [Dynamic expression of TGF-beta1/Smad protein in CCl4-induced liver fibrosis and its significance in rats].
Bao JF; Shi JP; Xu S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):334-7. PubMed ID: 22338217
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors.
Huang ML; Li X; Meng Y; Xiao B; Ma Q; Ying SS; Wu PS; Zhang ZS
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):e1-6. PubMed ID: 19793108
[TBL] [Abstract][Full Text] [Related]
15. [Effect of perindopril on renal interstitial fibrosis of hypertension in rats].
Xu H; Tao LJ; Sun M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 29(1):61-4. PubMed ID: 16137008
[TBL] [Abstract][Full Text] [Related]
16. Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes.
Qiang G; Zhang L; Yang X; Xuan Q; Shi L; Zhang H; Chen B; Li X; Zu M; Zhou D; Guo J; Yang H; Du G
Eur J Pharmacol; 2012 Jun; 685(1-3):156-64. PubMed ID: 22546234
[TBL] [Abstract][Full Text] [Related]
17. The protective effects of a fermented substance from Saccharomyces cerevisiae on carbon tetrachloride-induced liver damage in rats.
Lai JT; Hsieh WT; Fang HL; Lin WC
Clin Nutr; 2009 Jun; 28(3):338-45. PubMed ID: 19233522
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic effects of octreotide on hepatofibrosis-induced with carbon tetrachloride in rats].
Wang ZR; Li DG; Chen XM; Huang X; Wei HS; Wang YQ; Xu QF; Lu HM
Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):408-11. PubMed ID: 12890342
[TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.
Latella G; Vetuschi A; Sferra R; Catitti V; D'Angelo A; Zanninelli G; Flanders KC; Gaudio E
Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482
[TBL] [Abstract][Full Text] [Related]
20. [Effects of nuclear factor kappaB and transforming growth factor beta1 in the anti-liver fibrosis process using Ginkgo biloba extract].
Liu SQ; Yu JP; He L; Yu HG; Luo HS
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):903-7. PubMed ID: 16381635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
